SAREPTA THERAPEUTICS INC SAREPT (0L35.L) Financials

0L35.L Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 3.1 billion 2.3 billion
2023-06-30 3.1 billion 2.4 billion
2023-03-31 3.1 billion 2.3 billion
2022-12-31 3.1 billion 2.7 billion

0L35.L Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -155.6 million 48.1 million
2023-06-30 -140.1 million 47.4 million
2023-03-31 -218.9 million 41.3 million
2022-12-31 -100.4 million 50.5 million

0L35.L Net Income

No data available :(

0L35.L Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 1.7 billion - -
2023-06-30 1.9 billion - -
2023-03-31 1.9 billion - -
2022-12-31 2.0 billion - -

0L35.L Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 88.9 million
2023-06-30 88.7 million
2023-03-31 88.2 million
2022-12-31 87.8 million

0L35.L Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 40.9 million 186.2 million - -
2023-06-30 17.9 million 233.8 million - -
2023-03-31 9.5 million 237.1 million - -
2022-12-31 8.0 million 205.8 million - -

0L35.L Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 331.8 million 48.0 million
2023-06-30 261.2 million 44.9 million
2023-03-31 253.5 million 46.3 million
2022-12-31 258.4 million 41.4 million

0L35.L

Price: $129.94

52 week price:
55.68
155.48

Earnings Per Share: -4.29 USD

P/E Ratio: -29.89

Exchange: LSE

Sector: Healthcare

Industry: Pharmaceuticals, Biotechnology & Life Sciences

Market Capitalization: 105.9 million

Links: